— Regeneron Pharmaceuticals (NASDAQ: REGN) reported Q4 2019 earnings of $7.50 per share, vs. $6.92 expected. — Revenues grew 13% to $2.17 billion, vs. $2.11 billion expected. — Net product … Continue reading Regeneron Pharmaceuticals (REGN): Q4 2019 Earnings Snapshot